Anti-CGRP for Inflamation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia

Conditions:   Trigeminal Neuralgia;   Glossopharyngeal Neuralgia Intervention:   Drug: Galcanezumab Sponsors:   Duke University;   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials